Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Sara Beygi"'
Autor:
Caron Jacobson, Michael T. Hemmer, Zhen-Huan Hu, Matthew Frank, Leslie Popplewell, Nausheen Ahmed, Yi Lin, Timothy Best, Sara Beygi, Harry Miao, Christine Fu, Fang Sun, Hairong Xu, Marcelo Pasquini
Publikováno v:
HemaSphere, Vol 7, p e31464ce (2023)
Externí odkaz:
https://doaj.org/article/cb0ba1588289401d97a2ee6870194d92
Autor:
Ian W. Flinn, Caron Jacobson, Loretta J. Nastoupil, Franck Morschhauser, Andrew J. Davies, Christian Buske, Paolo Corradini, Armando Lopez-Guillermo, Ran Reshef, Vinod Parameswaran, Alison Sehgal, Michael Tees, Christine Lui, Wei Xue, Sara Beygi, Nikolay Grechko, Pisita Bolsue, Alessandro Giovanetti, Christina To, Myrna Nahas
Publikováno v:
HemaSphere, Vol 7, p e6350662 (2023)
Externí odkaz:
https://doaj.org/article/ef44d6a08f2940c4843d4ce92bfe510e
Autor:
Paola Ghione, M Lia Palomba, Hervé Ghesquieres, Sabela Bobillo, Anik R Patel, Myrna Nahas, Steve Kanters, Kevin Deighton, Anthony Hatswell, Long Ma, Eve H. Limbrick-Oldfield, Julia Thornton Snider, Sally W. Wade, Maria Teresa Riberio, John Radford, Sara Beygi, John Gribben
Publikováno v:
Haematologica, Vol 108, Iss 3 (2022)
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are limited. SCHOLAR-5 is a retrospective cohort study using data from adult
Externí odkaz:
https://doaj.org/article/604a1f99ccae4ab1b8ca2279a5620a97
Publikováno v:
Case Reports in Rheumatology, Vol 2017 (2017)
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by hypophosphatemia and clinical symptoms of osteomalacia. Only discussed as case reports, there is still limited knowledge of this condition as a potentially curable ca
Externí odkaz:
https://doaj.org/article/dc8100c715174564824f3d9cd298b611
Publikováno v:
Scientifica, Vol 2015 (2015)
We examined the effects of Ramadan fasting on cognitive function in 17 female athletes. Data were obtained from participants of two fasting (n=9) and nonfasting (n=8) groups at three periods of the study (before Ramadan, at the third week in Ramadan,
Externí odkaz:
https://doaj.org/article/75890ad652a04fbe9dad8a92f3c76573
Autor:
Ronald Levy, Ash A. Alizadeh, Ranjana H. Advani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, David M. Kurtz, Etelka Gabriel, Karen S. Corbelli, Alyssa M. Kanegai, Sara Beygi, Gladys M. Rodriguez, Joseph G. Schroers-Martin, Debra K. Czerwinski, Julian J.K. Lohmeyer, Vishnu Shankar, Tanaya Shree
Supplementary Data from CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e8a596f3480fe88d0d3f49612e3689
https://doi.org/10.1158/2643-3230.22544457.v1
https://doi.org/10.1158/2643-3230.22544457.v1
Autor:
Ronald Levy, Ash A. Alizadeh, Ranjana H. Advani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, David M. Kurtz, Etelka Gabriel, Karen S. Corbelli, Alyssa M. Kanegai, Sara Beygi, Gladys M. Rodriguez, Joseph G. Schroers-Martin, Debra K. Czerwinski, Julian J.K. Lohmeyer, Vishnu Shankar, Tanaya Shree
To obtain a deeper understanding of poor responses to COVID-19 vaccination in patients with lymphoma, we assessed blocking antibodies, total anti-spike IgG, and spike-specific memory B cells in the peripheral blood of 126 patients with lymphoma and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319f3d963c817b8fedded1bb2f93dcd3
https://doi.org/10.1158/2643-3230.c.6550647
https://doi.org/10.1158/2643-3230.c.6550647
Autor:
Ronald Levy, Ash A. Alizadeh, Ranjana H. Advani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, David M. Kurtz, Etelka Gabriel, Karen S. Corbelli, Alyssa M. Kanegai, Sara Beygi, Gladys M. Rodriguez, Joseph G. Schroers-Martin, Debra K. Czerwinski, Julian J.K. Lohmeyer, Vishnu Shankar, Tanaya Shree
Supplementary Figure from CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37aa78bb717dbdbf8b5dbe94202d7205
https://doi.org/10.1158/2643-3230.22544448
https://doi.org/10.1158/2643-3230.22544448
Autor:
Tanaya Shree, Vishnu Shankar, Julian J.K. Lohmeyer, Debra K. Czerwinski, Joseph G. Schroers-Martin, Gladys M. Rodriguez, Sara Beygi, Alyssa M. Kanegai, Karen S. Corbelli, Etelka Gabriel, David M. Kurtz, Michael S. Khodadoust, Neel K. Gupta, Lauren S. Maeda, Ranjana H. Advani, Ash A. Alizadeh, Ronald Levy
Publikováno v:
Blood Cancer Discov
To obtain a deeper understanding of poor responses to COVID-19 vaccination in patients with lymphoma, we assessed blocking antibodies, total anti-spike IgG, and spike-specific memory B cells in the peripheral blood of 126 patients with lymphoma and 2
Autor:
M Lia Palomba, Paola Ghione, Anik R Patel, Myrna Nahas, Sara Beygi, Anthony J Hatswell, Steve Kanters, Eve H. Limbrick-Oldfield, Sally W Wade, Markqayne D Ray, Jessica Owen, Sattva S Neelapu, John Gribben, John Radford, Sabela Bobillo
Publikováno v:
Palomba, M L, Ghione, P, Patel, A R, Nahas, M, Beygi, S, Hatswell, A J, Kanters, S, Limbrick-Oldfield, E H, Wade, S W, Ray, M D, Owen, J, Neelapu, S S, Gribben, J, Radford, J & Bobillo, S 2023, ' A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma ', Expert Review of Anticancer Therapy, vol. 23, no. 2, pp. 199-206 . https://doi.org/10.1080/14737140.2023.2171994
Scientia
Scientia
Follicular lymphoma; Axicabtagene ciloleucel; Comparative effectiveness Limfoma fol·licular; Axicabtagene ciloleucel; Eficàcia comparativa Linfoma folicular; Axicabtagene ciloleucel; Eficacia comparativa Background In the ZUMA-5 trial (Clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d727090bb434c68e1185c778daaf38